RET fusion-positive carcinomas were associated with aggressive disease, including frequent LNM and DM, especially in cases of NCOA4/RET-positive carcinomas, even in early-stage disease, and with increased rates in pediatric and adolescent patients. This evidence concerns the gene RET and carcinoma.